Atkinson Edward Morrow III
CIK 0001914164
EVP, Chief Technical Ops. Off.Director
Filings
26
Latest Feb 26, 2026
Issuers covered
2
Showing
26 of 26
Page 1
Track record
13 of 15 open-market trades scored (87% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 13 | 54% | -0.0% | +0.9% | +10.3% | -10.5% |
| 90 days | 13 | 62% | +1.5% | +2.8% | +9.8% | -10.0% |
| 180 days | 9 | 44% | +0.0% | -0.6% | +19.0% | -16.3% |
| 365 days | 8 | 13% | -6.2% | -6.7% | +3.3% | -14.5% |
Issuers
Companies where Atkinson Edward Morrow III has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc / Ma | 19 | Feb 26, 2026 |
| ETNB | 89bio, Inc. | 7 | Oct 30, 2025 |
All filings
26 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|